Illumina Responds to Positive Updates from Chinese Ministry of Commerce
Get Alerts ILMN Hot Sheet
Join SI Premium – FREE
Illumina remains focused on achieving a positive resolution regarding its inclusion on the UEL and is committed to serving customers in this important market. For two decades, Illumina has been proud to partner with customers in
"We are pleased with the announcement from MOFCOM, which is a very positive step forward. Illumina will continue to engage with authorities and stakeholders as we work toward a long-term resolution," said
Illumina is making no change to FY25 guidance, which was recently updated during the company's Q3 2025 earnings call.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on X, Facebook, LinkedIn, Instagram, TikTok, and YouTube.
Contacts
Investors:
Illumina Investor Relations
858-291-6421
[email protected]
Media:
[email protected]
View original content:https://www.prnewswire.com/news-releases/illumina-responds-to-positive-updates-from-chinese-ministry-of-commerce-302606280.html
SOURCE Illumina, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Exonate Becomes Foventa Therapeutics
- Global-Leading Robobrain Firm Mech-Mind Robotics Lists on Hong Kong Stock Exchange
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share